1.Schettler, T. Human exposure to phthalates via consumer products. Int J Androl. 2006; 29, 134–139.
2.Wormut, M. What are the sources of exposure to eight frequently used phthalic esters in Europeans? Risk Anal. 2006; 26, 803–824.
3.Hoppin, JA, Brock, JW, Davis, BJ, Baird, DD. Reproducibility of urinary phthalate metabolites in first morning urine samples. Environ Health Perspect. 2002; 110, 515–518.
4.Hauser, R, Meeker, JD, Park, S, Silva, MJ, Calafat, AM. Temporal variability of urinary phthalate metabolite levels in men of reproductive age. Environ Health Perspect. 2004; 112, 1734–1740.
5.Teitelbaum, SL, Britton, JA, Calafat, AM, et al. Temporal variability in urinary concentrations of phthalate metabolites, phytoestrogens and phenols among minority children in the United States. Environ Res. 2008; 106, 257–269.
6.Masutomi, N, Shibutani, M, Takagi, H, et al. Impact of dietary exposure to methoxychlor, genistein, or diisononyl phthalate during the perinatal period on the development of the rat endocrine/reproductive systems in later life. Toxicology. 2002; 192, 149–170.
7.Parks, LG, Ostby, JS, Lambright, CR, et al. The plasticizer diethylhexyl phthalate induces malformations by decreasing fetal testosterone synthesis during sexual differentiation in the male rat. Toxicol Sci. 2000; 58, 339–349.
8.Ema, M, Miyawaki, E. Adverse effects on development of the reproductive system in male offspring of rats given monobutyl phthalate, a metabolite of dibutyl phthalate during late pregnancy. Reprod Toxicol. 2001; 15, 189–194.
9.Gray, TJB, Beamand, JA. Effect of some phthalate esters and other testicular toxins on primary cultures of testicular cells. Food Chem Toxicol. 1984; 22, 123–131.
10.Nakahara, H, Shono, T, Suita, S. Effects of prenatal exposure to phthalate ester on both testicular descent and urogenital development in rats. Fukuoka Igaku Zasshi. 2003; 94, 331–337.
11.Swan, SH, Main, KM, Liu, F, et al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect. 2005; 113, 1056–1061.
12.Swan, SH. Environmental phthalate exposure in relation to reproductive outcomes and other health endpoints in humans. Environ Res. 2008; 108, 177–184.
13.Suzuki, Y, Yoshinaga, J, Mizumoto, Y, Serizawa, S, Shiraishi, H. Foetal exposure to phthalate esters and anogenital distance in male newborns. Intl J Androl. 2012; 35, 236–244.
14.Huang, PC, Kuo, PL, Chou, YY, Lin, SJ, Lee, CC. Association between prenatal exposure to phthalates and the health of newborns. Environ Int. 2009; 35, 14–20.
15.Salazar-Martínez, E, Romano-Riquer, P, Yáñez-Márquez, E, Longnecker, MP, Hernandez-Avila, M. Anogenital distance in human male and female newborns: a descriptive, cross-sectional study. Environ Health. 2005; 3, 8–13.
16.Capurro, H, Konichezky, S, Fonseca, D, Caldeyro-Barcia, R. A simplified method for diagnosis of gestational age in the newborn infant. J Pediatr. 1978; 93, 120–122.
17.Albro, PW, Jordan, ST, Schroeder, JL, Corbett, JT. Chromatographic separation and quantitative determination of metabolites of di-(2 ethylhexyl)phthalate from urine of laboratory animals. J Chromatogr. 1982; 244, 65–79.
18.Blount, BC, Milgram, KE, Silva, MJ, et al. Quantitative detection of eight phthalate metabolites in human urine using HPLC-APCI-MS/MS. Anal Chem. 2000; 72, 4127–4134.
19.García, MA, Soberón, E, Cortez, M, Rodríguez, R, Herrera, JL. Métodos analíticos Guía de validación; Colegio Nacional de Químicos Farmacéuticos Biólogos A. C: México 2002.
20.Adibi, JJ, Whyatt, RM, Paige, LW, et al. Characterization of phthalate exposure among pregnant women assessed by repeat air and urine samples. Environ Health Perspect. 2008; 116, 467–473.
21.Svensson, K, Hernández-Ramírez, RU, Burguete-García, A, et al. Phthalate exposure associated with self-reported diabetes among Mexican women. Environ Res. 2011; 111, 792–796.
22.Romero-Franco, M, Hernández-Ramírez, RU, Calafat, AM, et al. Personal care product use and urinary levels of phthalate metabolites in Mexican women. Environ Int. 2011; 37, 867–871.
23.Romano-Riquer, SP, Hernández-Ávila, M, Gladen, BC, Cupul-Uicab, LA, Longnecker, MP. Reliability and determinants of anogenital distance and penis dimensions in male newborns from Chiapas, Mexico. Paediatr Perinat Epidemiol. 2007; 21, 219–228.
24.Fok, TF, Hon, KL, So, HK, et al. The Hong Kong Neonatal Measurements Working Group. Normative data of penile length for term Chinese newborns. Biol Neonate. 2005; 87, 242–245.
25.Anigstein, CR. Longitud y diámetro del pene en niños de 0 a 14 años de edad. Arch Argent Pediatr. 2005; 103, 401–405.
26.Damon, V, Berlier, P, Durozier, B, Francois, R. Study of the dimensions of the penis from birth to adult age and as a function of testicular volume. Pediatrie. 1990; 45, 519–522.
27.Carmudan, AD, Oz, MO, Ilhan, MN, et al. Current stretched penile length: cross-sectional study of 1040 healthy Turkish children aged 0 to 5 years. Urology. 2007; 70, 572–575.
28.Al-Herbish, AS. Standard penile size for normal full term newborns in the Saudi population. Saudi Med J. 2002; 23, 314–316.
29.Fujieda, K, Matsuura, N. Growth and maturation in male genitalia from birth to adolescence II. Change of penile length. Pediatr Int. 1987; 29, 220–223.
30.Lee, PA, Mazur, T, Danish, R, et al. Micropenis I. Criteria, etiologies and classification. Johns Hopkins Med J. 1980; 146, 156–163.
31.Anhalt, H, Neely, EK, Hintz, RL. Ambiguous genitalia. Pediatr Rev. 1996; 17, 213–220.
32.Mendiola, J, Stahlnut, RW, Jorgensen, N, Liu, F, Swan, SH. Shorter anogenital distance predicts poorer semen quality in young men in Rochester, New York. Environ Health Pers. 2011; 119, 958–963.
33.Bowman, CJ, Barlow, NJ, Turner, KJ, Wallace, DG, Foster, PMD. Effects of in utero exposure to finasteride on androgen-dependent reproductive development in the male rats. Toxicol Sci. 2003; 74, 393–406.
34.Ge, RS, Chen, GR, Tanrikut, C, Hardy, MP. Phthalate ester toxicity in Leydig cells: developmental timing and dosage considerations. Reprod Toxicol. 2007; 23, 366–373.
35.Chen, GR, Dong, L, Ge, RS, Hardy, MP. Relationship between phthalates and testicular dysgenesis syndrome. Zhonghua Nan Ke Xue. 2007; 13, 195–200.
36.Welsh, M, Saunders, PTK, Fisken, M, et al. Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. J Clin Invest. 2008; 118, 1479–1490.